Financials Akzo Nobel N.V.

Equities

AKZA

NL0013267909

Commodity Chemicals

Market Closed - Euronext Amsterdam 09:05:07 26/04/2024 pm IST 5-day change 1st Jan Change
62.76 EUR +1.36% Intraday chart for Akzo Nobel N.V. -5.31% -16.12%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 18,092 16,933 17,600 11,098 12,764 10,707 - -
Enterprise Value (EV) 1 18,894 17,967 19,998 15,187 16,549 14,261 13,959 13,548
P/E ratio 37.5 x 26.5 x 21.6 x 31.1 x 28.9 x 16.7 x 14.3 x 12.8 x
Yield 2.1% 2.22% 2.05% 3.16% 2.65% 3.2% 3.32% 3.52%
Capitalization / Revenue 1.95 x 1.99 x 1.84 x 1.02 x 1.2 x 0.99 x 0.97 x 0.94 x
EV / Revenue 2.04 x 2.11 x 2.09 x 1.4 x 1.55 x 1.32 x 1.26 x 1.19 x
EV / EBITDA 14.1 x 12.5 x 13.9 x 13.1 x 11.6 x 9.12 x 8.3 x 7.59 x
EV / FCF -104 x 18.7 x 63.1 x -524 x 19.7 x 20.4 x 18.9 x 16.4 x
FCF Yield -0.96% 5.35% 1.59% -0.19% 5.08% 4.89% 5.3% 6.1%
Price to Book 3.04 x 2.93 x 3.29 x 2.52 x 2.95 x 2.28 x 2.08 x 1.9 x
Nbr of stocks (in thousands) 1,99,600 1,92,726 1,82,386 1,77,400 1,70,595 1,70,601 - -
Reference price 2 90.64 87.86 96.50 62.56 74.82 62.76 62.76 62.76
Announcement Date 12/02/20 17/02/21 09/02/22 08/02/23 07/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,276 8,530 9,587 10,846 10,668 10,771 11,089 11,402
EBITDA 1 1,341 1,442 1,436 1,157 1,429 1,564 1,682 1,785
EBIT 1 991 1,099 1,092 789 1,074 1,218 1,326 1,422
Operating Margin 10.68% 12.88% 11.39% 7.27% 10.07% 11.31% 11.96% 12.47%
Earnings before Tax (EBT) 1 785 919 1,105 602 784 973 1,131 1,233
Net income 1 539 630 829 352 442 638.7 734.2 821
Net margin 5.81% 7.39% 8.65% 3.25% 4.14% 5.93% 6.62% 7.2%
EPS 2 2.420 3.320 4.460 2.010 2.590 3.768 4.391 4.893
Free Cash Flow 1 -181 962 317 -29 840 697.8 739.9 826.1
FCF margin -1.95% 11.28% 3.31% -0.27% 7.87% 6.48% 6.67% 7.25%
FCF Conversion (EBITDA) - 66.71% 22.08% - 58.78% 44.61% 44% 46.29%
FCF Conversion (Net income) - 152.7% 38.24% - 190.05% 109.25% 100.77% 100.62%
Dividend per Share 2 1.900 1.950 1.980 1.980 1.980 2.005 2.084 2.208
Announcement Date 12/02/20 17/02/21 09/02/22 08/02/23 07/02/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,403 2,525 2,853 2,862 2,606 2,657 2,741 2,741 2,529 2,640 2,777 2,781 2,559 2,692 -
EBITDA 1 301 317 337 283 220 305 397 414 313 363 442.5 445.1 335.1 - -
EBIT 1 209 230 249 184 126 218 311 324 221 274 354.4 354.8 235.2 268.3 -
Operating Margin 8.7% 9.11% 8.73% 6.43% 4.83% 8.2% 11.35% 11.82% 8.74% 10.38% 12.76% 12.76% 9.19% 9.97% -
Earnings before Tax (EBT) 1 202 - 182 141 51 151 239 294 100 - 290 296 180 - -
Net income 1 187 154 106 84 8 94 118 189 41 181 195 199 118 - -
Net margin 7.78% 6.1% 3.72% 2.94% 0.31% 3.54% 4.3% 6.9% 1.62% 6.86% 7.02% 7.16% 4.61% - -
EPS 2 1.030 0.8600 0.6000 0.4800 0.0500 0.5500 0.6900 1.110 0.2400 1.060 1.220 1.180 0.4800 0.9300 -
Dividend per Share 2 1.540 - - - 1.540 - - - 1.540 - - - 2.100 - -
Announcement Date 09/02/22 21/04/22 20/07/22 20/10/22 08/02/23 25/04/23 25/07/23 25/10/23 07/02/24 23/04/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 802 1,034 2,398 4,089 3,785 3,554 3,252 2,842
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.5981 x 0.7171 x 1.67 x 3.534 x 2.649 x 2.272 x 1.934 x 1.592 x
Free Cash Flow 1 -181 962 317 -29 840 698 740 826
ROE (net income / shareholders' equity) 7.26% 12.3% 13.5% 8.77% 12.1% 15.4% 16.3% 16.8%
ROA (Net income/ Total Assets) 4.16% 5.67% 5.57% 2.99% 3.57% 5.02% 5.71% 6.19%
Assets 1 12,972 11,106 14,893 11,769 12,381 12,727 12,851 13,262
Book Value Per Share 2 29.80 30.00 29.30 24.80 25.30 27.60 30.10 33.00
Cash Flow per Share 2 0.1500 6.370 3.270 1.510 6.600 6.230 6.790 7.170
Capex 1 214 258 288 292 286 350 360 364
Capex / Sales 2.31% 3.02% 3% 2.69% 2.68% 3.25% 3.25% 3.19%
Announcement Date 12/02/20 17/02/21 09/02/22 08/02/23 07/02/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
62.76 EUR
Average target price
78.39 EUR
Spread / Average Target
+24.90%
Consensus
  1. Stock Market
  2. Equities
  3. AKZA Stock
  4. Financials Akzo Nobel N.V.